Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
Product: | Caspofungin Apotex |
Active Ingredient: | Caspofungin acetate 55.52mg equivalent to caspofungin 50mg |
Dosage Form: | Powder for infusion concentrate |
New Zealand Sponsor: | Apotex NZ Limited |
Manufacturer: | Mefar Ilac Sanayii A.S., Istanbul, Turkey |
Product: | Caspofungin Apotex |
Active Ingredient: | Caspofungin acetate 77.69mg equivalent to caspofungin 70mg |
Dosage Form: | Powder for infusion concentrate |
New Zealand Sponsor: | Apotex NZ Limited |
Manufacturer: | Mefar Ilac Sanayii A.S., Istanbul, Turkey |
Product: | Ziextenzo |
Active Ingredient: | Pegfilgrastim 10mg/mL |
Dosage Form: | Solution for injection |
New Zealand Sponsor: | Novartis New Zealand Limited |
Manufacturer: | Sandoz GmbH, Langkampfen, Austria |
Dated this 26th day of March 2020.
CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).